Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 73
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 73,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'catslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 73,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/sc-ruling-on-clinical-trials-24811/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/sc-ruling-on-clinical-trials-24811/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'catslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 73
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Deprecated (16384): The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php. [CORE/src/Core/functions.php, line 311]
Code Context


        trigger_error($message, E_USER_DEPRECATED);

    }
$message = 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead. - /home/brlfuser/public_html/src/Controller/ArtileDetailController.php, line: 74
 You can disable deprecation warnings by setting `Error.errorLevel` to `E_ALL & ~E_USER_DEPRECATED` in your config/app.php.'
$stackFrame = (int) 1
$trace = [
	(int) 0 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ServerRequest.php',
		'line' => (int) 2421,
		'function' => 'deprecationWarning',
		'args' => [
			(int) 0 => 'The ArrayAccess methods will be removed in 4.0.0.Use getParam(), getData() and getQuery() instead.'
		]
	],
	(int) 1 => [
		'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
		'line' => (int) 74,
		'function' => 'offsetGet',
		'class' => 'Cake\Http\ServerRequest',
		'object' => object(Cake\Http\ServerRequest) {},
		'type' => '->',
		'args' => [
			(int) 0 => 'artileslug'
		]
	],
	(int) 2 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Controller/Controller.php',
		'line' => (int) 610,
		'function' => 'printArticle',
		'class' => 'App\Controller\ArtileDetailController',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 3 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 120,
		'function' => 'invokeAction',
		'class' => 'Cake\Controller\Controller',
		'object' => object(App\Controller\ArtileDetailController) {},
		'type' => '->',
		'args' => []
	],
	(int) 4 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/ActionDispatcher.php',
		'line' => (int) 94,
		'function' => '_invoke',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(App\Controller\ArtileDetailController) {}
		]
	],
	(int) 5 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/BaseApplication.php',
		'line' => (int) 235,
		'function' => 'dispatch',
		'class' => 'Cake\Http\ActionDispatcher',
		'object' => object(Cake\Http\ActionDispatcher) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 6 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Http\BaseApplication',
		'object' => object(App\Application) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 7 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/RoutingMiddleware.php',
		'line' => (int) 162,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 8 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\RoutingMiddleware',
		'object' => object(Cake\Routing\Middleware\RoutingMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 9 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Routing/Middleware/AssetMiddleware.php',
		'line' => (int) 88,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 10 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Routing\Middleware\AssetMiddleware',
		'object' => object(Cake\Routing\Middleware\AssetMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 11 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Middleware/ErrorHandlerMiddleware.php',
		'line' => (int) 96,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 12 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 65,
		'function' => '__invoke',
		'class' => 'Cake\Error\Middleware\ErrorHandlerMiddleware',
		'object' => object(Cake\Error\Middleware\ErrorHandlerMiddleware) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {},
			(int) 2 => object(Cake\Http\Runner) {}
		]
	],
	(int) 13 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Runner.php',
		'line' => (int) 51,
		'function' => '__invoke',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\ServerRequest) {},
			(int) 1 => object(Cake\Http\Response) {}
		]
	],
	(int) 14 => [
		'file' => '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Http/Server.php',
		'line' => (int) 98,
		'function' => 'run',
		'class' => 'Cake\Http\Runner',
		'object' => object(Cake\Http\Runner) {},
		'type' => '->',
		'args' => [
			(int) 0 => object(Cake\Http\MiddlewareQueue) {},
			(int) 1 => object(Cake\Http\ServerRequest) {},
			(int) 2 => object(Cake\Http\Response) {}
		]
	],
	(int) 15 => [
		'file' => '/home/brlfuser/public_html/webroot/index.php',
		'line' => (int) 39,
		'function' => 'run',
		'class' => 'Cake\Http\Server',
		'object' => object(Cake\Http\Server) {},
		'type' => '->',
		'args' => []
	]
]
$frame = [
	'file' => '/home/brlfuser/public_html/src/Controller/ArtileDetailController.php',
	'line' => (int) 74,
	'function' => 'offsetGet',
	'class' => 'Cake\Http\ServerRequest',
	'object' => object(Cake\Http\ServerRequest) {
		trustProxy => false
		[protected] params => [
			[maximum depth reached]
		]
		[protected] data => [[maximum depth reached]]
		[protected] query => [[maximum depth reached]]
		[protected] cookies => [
			[maximum depth reached]
		]
		[protected] _environment => [
			[maximum depth reached]
		]
		[protected] url => 'latest-news-updates/sc-ruling-on-clinical-trials-24811/print'
		[protected] base => ''
		[protected] webroot => '/'
		[protected] here => '/latest-news-updates/sc-ruling-on-clinical-trials-24811/print'
		[protected] trustedProxies => [[maximum depth reached]]
		[protected] _input => null
		[protected] _detectors => [
			[maximum depth reached]
		]
		[protected] _detectorCache => [
			[maximum depth reached]
		]
		[protected] stream => object(Zend\Diactoros\PhpInputStream) {}
		[protected] uri => object(Zend\Diactoros\Uri) {}
		[protected] session => object(Cake\Http\Session) {}
		[protected] attributes => [[maximum depth reached]]
		[protected] emulatedAttributes => [
			[maximum depth reached]
		]
		[protected] uploadedFiles => [[maximum depth reached]]
		[protected] protocol => null
		[protected] requestTarget => null
		[private] deprecatedProperties => [
			[maximum depth reached]
		]
	},
	'type' => '->',
	'args' => [
		(int) 0 => 'artileslug'
	]
]
deprecationWarning - CORE/src/Core/functions.php, line 311
Cake\Http\ServerRequest::offsetGet() - CORE/src/Http/ServerRequest.php, line 2421
App\Controller\ArtileDetailController::printArticle() - APP/Controller/ArtileDetailController.php, line 74
Cake\Controller\Controller::invokeAction() - CORE/src/Controller/Controller.php, line 610
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 120
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51
Cake\Http\Server::run() - CORE/src/Http/Server.php, line 98

Warning (512): Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853 [CORE/src/Http/ResponseEmitter.php, line 48]
Code Context
            if (Configure::read('debug')) {

                trigger_error($message, E_USER_WARNING);

            } else {
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-trace').style.display = (document.getElementById('cakeErr67f3b0ee74f17-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3b0ee74f17-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-code').style.display = (document.getElementById('cakeErr67f3b0ee74f17-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-context').style.display = (document.getElementById('cakeErr67f3b0ee74f17-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3b0ee74f17-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3b0ee74f17-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24630,
		&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24811,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24630,
	&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24811,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24630
$metaTitle = &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;
$metaKeywords = &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;
$metaDesc = &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-ruling-on-clinical-trials-24811.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | SC ruling on clinical trials | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


&nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>SC ruling on clinical trials</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Telegraph</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.</p><p style="text-align: justify">A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.</p><p style="text-align: justify">The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.</p><p style="text-align: justify">The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.</p><p style="text-align: justify">The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.</p><p style="text-align: justify">The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.</p><p style="text-align: justify">Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.</p><p style="text-align: justify">The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.</p><p style="text-align: justify">The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.</p><p style="text-align: justify">&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$maxBufferLength = (int) 8192
$file = '/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php'
$line = (int) 853
$message = 'Unable to emit headers. Headers sent in file=/home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php line=853'
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 48
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 148]
Code Context
            $response->getStatusCode(),

            ($reasonPhrase ? ' ' . $reasonPhrase : '')

        ));
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-trace').style.display = (document.getElementById('cakeErr67f3b0ee74f17-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3b0ee74f17-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-code').style.display = (document.getElementById('cakeErr67f3b0ee74f17-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-context').style.display = (document.getElementById('cakeErr67f3b0ee74f17-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3b0ee74f17-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3b0ee74f17-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24630,
		&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24811,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24630,
	&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24811,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24630
$metaTitle = &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;
$metaKeywords = &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;
$metaDesc = &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-ruling-on-clinical-trials-24811.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | SC ruling on clinical trials | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


&nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>SC ruling on clinical trials</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Telegraph</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.</p><p style="text-align: justify">A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.</p><p style="text-align: justify">The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.</p><p style="text-align: justify">The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.</p><p style="text-align: justify">The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.</p><p style="text-align: justify">The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.</p><p style="text-align: justify">Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.</p><p style="text-align: justify">The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.</p><p style="text-align: justify">The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.</p><p style="text-align: justify">&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$reasonPhrase = 'OK'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitStatusLine() - CORE/src/Http/ResponseEmitter.php, line 148
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 54
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

Warning (2): Cannot modify header information - headers already sent by (output started at /home/brlfuser/public_html/vendor/cakephp/cakephp/src/Error/Debugger.php:853) [CORE/src/Http/ResponseEmitter.php, line 181]
Code Context
                    $value

                ), $first);

                $first = false;
$response = object(Cake\Http\Response) {

	'status' => (int) 200,
	'contentType' => 'text/html',
	'headers' => [
		'Content-Type' => [
			[maximum depth reached]
		]
	],
	'file' => null,
	'fileRange' => [],
	'cookies' => object(Cake\Http\Cookie\CookieCollection) {},
	'cacheDirectives' => [],
	'body' => '<!DOCTYPE html PUBLIC "-//W3C//DTD XHTML 1.0 Transitional//EN"
        "http://www.w3.org/TR/xhtml1/DTD/xhtml1-transitional.dtd">
<html xmlns="http://www.w3.org/1999/xhtml">
<head>
    <link rel="canonical" href="https://im4change.in/<pre class="cake-error"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-trace').style.display = (document.getElementById('cakeErr67f3b0ee74f17-trace').style.display == 'none' ? '' : 'none');"><b>Notice</b> (8)</a>: Undefined variable: urlPrefix [<b>APP/Template/Layout/printlayout.ctp</b>, line <b>8</b>]<div id="cakeErr67f3b0ee74f17-trace" class="cake-stack-trace" style="display: none;"><a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-code').style.display = (document.getElementById('cakeErr67f3b0ee74f17-code').style.display == 'none' ? '' : 'none')">Code</a> <a href="javascript:void(0);" onclick="document.getElementById('cakeErr67f3b0ee74f17-context').style.display = (document.getElementById('cakeErr67f3b0ee74f17-context').style.display == 'none' ? '' : 'none')">Context</a><pre id="cakeErr67f3b0ee74f17-code" class="cake-code-dump" style="display: none;"><code><span style="color: #000000"><span style="color: #0000BB"></span><span style="color: #007700">&lt;</span><span style="color: #0000BB">head</span><span style="color: #007700">&gt;
</span></span></code>
<span class="code-highlight"><code><span style="color: #000000">&nbsp;&nbsp;&nbsp;&nbsp;&lt;link&nbsp;rel="canonical"&nbsp;href="<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">Configure</span><span style="color: #007700">::</span><span style="color: #0000BB">read</span><span style="color: #007700">(</span><span style="color: #DD0000">'SITE_URL'</span><span style="color: #007700">);&nbsp;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$urlPrefix</span><span style="color: #007700">;</span><span style="color: #0000BB">?&gt;&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">category</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">slug</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>/<span style="color: #0000BB">&lt;?php&nbsp;</span><span style="color: #007700">echo&nbsp;</span><span style="color: #0000BB">$article_current</span><span style="color: #007700">-&gt;</span><span style="color: #0000BB">seo_url</span><span style="color: #007700">;&nbsp;</span><span style="color: #0000BB">?&gt;</span>.html"/&gt;
</span></code></span>
<code><span style="color: #000000"><span style="color: #0000BB">&nbsp;&nbsp;&nbsp;&nbsp;</span><span style="color: #007700">&lt;</span><span style="color: #0000BB">meta&nbsp;http</span><span style="color: #007700">-</span><span style="color: #0000BB">equiv</span><span style="color: #007700">=</span><span style="color: #DD0000">"Content-Type"&nbsp;</span><span style="color: #0000BB">content</span><span style="color: #007700">=</span><span style="color: #DD0000">"text/html;&nbsp;charset=utf-8"</span><span style="color: #007700">/&gt;
</span></span></code></pre><pre id="cakeErr67f3b0ee74f17-context" class="cake-context" style="display: none;">$viewFile = &#039;/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp&#039;
$dataForView = [
	&#039;article_current&#039; =&gt; object(App\Model\Entity\Article) {

		&#039;id&#039; =&gt; (int) 24630,
		&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
		&#039;subheading&#039; =&gt; &#039;&#039;,
		&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
		&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
		&#039;article_img&#039; =&gt; &#039;&#039;,
		&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
		&#039;status&#039; =&gt; (int) 1,
		&#039;show_on_home&#039; =&gt; (int) 1,
		&#039;lang&#039; =&gt; &#039;EN&#039;,
		&#039;category_id&#039; =&gt; (int) 16,
		&#039;tag_keyword&#039; =&gt; &#039;&#039;,
		&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
		&#039;meta_title&#039; =&gt; null,
		&#039;meta_keywords&#039; =&gt; null,
		&#039;meta_description&#039; =&gt; null,
		&#039;noindex&#039; =&gt; (int) 0,
		&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
		&#039;most_visit_section_id&#039; =&gt; null,
		&#039;article_big_img&#039; =&gt; null,
		&#039;liveid&#039; =&gt; (int) 24811,
		&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
		&#039;edate&#039; =&gt; &#039;&#039;,
		&#039;tags&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
		&#039;[new]&#039; =&gt; false,
		&#039;[accessible]&#039; =&gt; [
			[maximum depth reached]
		],
		&#039;[dirty]&#039; =&gt; [[maximum depth reached]],
		&#039;[original]&#039; =&gt; [[maximum depth reached]],
		&#039;[virtual]&#039; =&gt; [[maximum depth reached]],
		&#039;[hasErrors]&#039; =&gt; false,
		&#039;[errors]&#039; =&gt; [[maximum depth reached]],
		&#039;[invalid]&#039; =&gt; [[maximum depth reached]],
		&#039;[repository]&#039; =&gt; &#039;Articles&#039;
	
	},
	&#039;articleid&#039; =&gt; (int) 24630,
	&#039;metaTitle&#039; =&gt; &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;,
	&#039;metaKeywords&#039; =&gt; &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;,
	&#039;metaDesc&#039; =&gt; &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;,
	&#039;disp&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;,
	&#039;lang&#039; =&gt; &#039;English&#039;,
	&#039;SITE_URL&#039; =&gt; &#039;https://im4change.in/&#039;,
	&#039;site_title&#039; =&gt; &#039;im4change&#039;,
	&#039;adminprix&#039; =&gt; &#039;admin&#039;
]
$article_current = object(App\Model\Entity\Article) {

	&#039;id&#039; =&gt; (int) 24630,
	&#039;title&#039; =&gt; &#039;SC ruling on clinical trials&#039;,
	&#039;subheading&#039; =&gt; &#039;&#039;,
	&#039;description&#039; =&gt; &#039;&lt;div style=&quot;text-align: justify&quot;&gt;
-The Telegraph
&lt;/div&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;nbsp;
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
&lt;/p&gt;
&lt;p style=&quot;text-align: justify&quot;&gt;
&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
&lt;/p&gt;&#039;,
	&#039;credit_writer&#039; =&gt; &#039;The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI&#039;,
	&#039;article_img&#039; =&gt; &#039;&#039;,
	&#039;article_img_thumb&#039; =&gt; &#039;&#039;,
	&#039;status&#039; =&gt; (int) 1,
	&#039;show_on_home&#039; =&gt; (int) 1,
	&#039;lang&#039; =&gt; &#039;EN&#039;,
	&#039;category_id&#039; =&gt; (int) 16,
	&#039;tag_keyword&#039; =&gt; &#039;&#039;,
	&#039;seo_url&#039; =&gt; &#039;sc-ruling-on-clinical-trials-24811&#039;,
	&#039;meta_title&#039; =&gt; null,
	&#039;meta_keywords&#039; =&gt; null,
	&#039;meta_description&#039; =&gt; null,
	&#039;noindex&#039; =&gt; (int) 0,
	&#039;publish_date&#039; =&gt; object(Cake\I18n\FrozenDate) {},
	&#039;most_visit_section_id&#039; =&gt; null,
	&#039;article_big_img&#039; =&gt; null,
	&#039;liveid&#039; =&gt; (int) 24811,
	&#039;created&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;modified&#039; =&gt; object(Cake\I18n\FrozenTime) {},
	&#039;edate&#039; =&gt; &#039;&#039;,
	&#039;tags&#039; =&gt; [
		(int) 0 =&gt; object(Cake\ORM\Entity) {},
		(int) 1 =&gt; object(Cake\ORM\Entity) {},
		(int) 2 =&gt; object(Cake\ORM\Entity) {},
		(int) 3 =&gt; object(Cake\ORM\Entity) {},
		(int) 4 =&gt; object(Cake\ORM\Entity) {}
	],
	&#039;category&#039; =&gt; object(App\Model\Entity\Category) {},
	&#039;[new]&#039; =&gt; false,
	&#039;[accessible]&#039; =&gt; [
		&#039;*&#039; =&gt; true,
		&#039;id&#039; =&gt; false
	],
	&#039;[dirty]&#039; =&gt; [],
	&#039;[original]&#039; =&gt; [],
	&#039;[virtual]&#039; =&gt; [],
	&#039;[hasErrors]&#039; =&gt; false,
	&#039;[errors]&#039; =&gt; [],
	&#039;[invalid]&#039; =&gt; [],
	&#039;[repository]&#039; =&gt; &#039;Articles&#039;

}
$articleid = (int) 24630
$metaTitle = &#039;LATEST NEWS UPDATES | SC ruling on clinical trials&#039;
$metaKeywords = &#039;medicines,Clinical Trials,drug trial,Health,Law and Justice&#039;
$metaDesc = &#039;
-The Telegraph


&amp;nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...&#039;
$disp = &#039;&lt;div style=&quot;text-align: justify&quot;&gt;-The Telegraph&lt;/div&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;nbsp;&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&lt;em&gt;New Delhi: &lt;/em&gt;The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The NGO&#039;s petition has alleged that many patients in India have been used by pharmaceutical companies as &amp;quot;guinea pigs&amp;quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The court also asked why the government does not set up a &amp;quot;body or an office&amp;quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &amp;quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don&#039;t know how much suffering a person must be undergoing,&amp;quot; the bench said.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The Supreme Court had last month expressed shock at what it said was a &amp;quot;disturbing&amp;quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.&lt;/p&gt;&lt;p style=&quot;text-align: justify&quot;&gt;&amp;quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&amp;quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.&lt;/p&gt;&#039;
$lang = &#039;English&#039;
$SITE_URL = &#039;https://im4change.in/&#039;
$site_title = &#039;im4change&#039;
$adminprix = &#039;admin&#039;</pre><pre class="stack-trace">include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51</pre></div></pre>latest-news-updates/sc-ruling-on-clinical-trials-24811.html"/>
    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>
    <link href="https://im4change.in/css/control.css" rel="stylesheet" type="text/css"
          media="all"/>
    <title>LATEST NEWS UPDATES | SC ruling on clinical trials | Im4change.org</title>
    <meta name="description" content="
-The Telegraph


&nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of..."/>
    <script src="https://im4change.in/js/jquery-1.10.2.js"></script>
    <script type="text/javascript" src="https://im4change.in/js/jquery-migrate.min.js"></script>
    <script language="javascript" type="text/javascript">

        $(document).ready(function () {
            var img = $("img")[0]; // Get my img elem
            var pic_real_width, pic_real_height;
            $("<img/>") // Make in memory copy of image to avoid css issues
                .attr("src", $(img).attr("src"))
                .load(function () {
                    pic_real_width = this.width;   // Note: $(this).width() will not
                    pic_real_height = this.height; // work for in memory images.
                });
        });
    </script>
    <style type="text/css">
        @media screen {
            div.divFooter {
                display: block;
            }
        }

        @media print {
            .printbutton {
                display: none !important;
            }
        }
    </style>
</head>
<body>
<table cellpadding="0" cellspacing="0" border="0" width="98%" align="center">
    <tr>
        <td class="top_bg">
            <div class="divFooter">
                <img src="https://im4change.in/images/logo1.jpg" height="59" border="0"
                     alt="Resource centre on India's rural distress" style="padding-top:14px;"/>
            </div>

        </td>
    </tr>
    <tr>
        <td id="topspace">&nbsp;</td>
    </tr>

    <tr id="topspace">
        <td>&nbsp;</td>
    </tr>
    <tr>
        <td height="50" style="border-bottom:1px solid #000; padding-top:10px;" class="printbutton">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>

    <tr>
        <td width="100%">
            <h1 class="news_headlines" style="font-style:normal">
                <strong>SC ruling on clinical trials</strong></h1>
        </td>
    </tr>
    <tr>
        <td width="100%" style="font-family:Arial, 'Segoe Script', 'Segoe UI', sans-serif, serif"><font size="3">
                <div style="text-align: justify">-The Telegraph</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.</p><p style="text-align: justify">A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.</p><p style="text-align: justify">The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.</p><p style="text-align: justify">The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.</p><p style="text-align: justify">The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.</p><p style="text-align: justify">The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.</p><p style="text-align: justify">Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.</p><p style="text-align: justify">The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.</p><p style="text-align: justify">The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.</p><p style="text-align: justify">&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.</p>               </font>
        </td>
    </tr>
    <tr>
        <td>&nbsp;</td>
    </tr>

    <tr>
        <td height="50" style="border-top:1px solid #000; border-bottom:1px solid #000;padding-top:10px;">
            <form><input type="button" value=" Print this page "
                         onclick="window.print();return false;"/></form>
        </td>
    </tr>
</table></body>
</html>'

}
$cookies = []
$values = [
	(int) 0 => 'text/html; charset=UTF-8'
]
$name = 'Content-Type'
$first = true
$value = 'text/html; charset=UTF-8'
header - [internal], line ??
Cake\Http\ResponseEmitter::emitHeaders() - CORE/src/Http/ResponseEmitter.php, line 181
Cake\Http\ResponseEmitter::emit() - CORE/src/Http/ResponseEmitter.php, line 55
Cake\Http\Server::emit() - CORE/src/Http/Server.php, line 141
[main] - ROOT/webroot/index.php, line 39

<head>

    <link rel="canonical" href="<?php echo Configure::read('SITE_URL'); ?><?php echo $urlPrefix;?><?php echo $article_current->category->slug; ?>/<?php echo $article_current->seo_url; ?>.html"/>

    <meta http-equiv="Content-Type" content="text/html; charset=utf-8"/>

$viewFile = '/home/brlfuser/public_html/src/Template/Layout/printlayout.ctp'
$dataForView = [
	'article_current' => object(App\Model\Entity\Article) {

		'id' => (int) 24630,
		'title' => 'SC ruling on clinical trials',
		'subheading' => '',
		'description' => '<div style="text-align: justify">
-The Telegraph
</div>
<p style="text-align: justify">
&nbsp;
</p>
<p style="text-align: justify">
<em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
</p>
<p style="text-align: justify">
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
</p>
<p style="text-align: justify">
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
</p>
<p style="text-align: justify">
The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
</p>
<p style="text-align: justify">
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
</p>
<p style="text-align: justify">
The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
</p>
<p style="text-align: justify">
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.
</p>
<p style="text-align: justify">
The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
</p>
<p style="text-align: justify">
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
</p>
<p style="text-align: justify">
&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
</p>',
		'credit_writer' => 'The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI',
		'article_img' => '',
		'article_img_thumb' => '',
		'status' => (int) 1,
		'show_on_home' => (int) 1,
		'lang' => 'EN',
		'category_id' => (int) 16,
		'tag_keyword' => '',
		'seo_url' => 'sc-ruling-on-clinical-trials-24811',
		'meta_title' => null,
		'meta_keywords' => null,
		'meta_description' => null,
		'noindex' => (int) 0,
		'publish_date' => object(Cake\I18n\FrozenDate) {},
		'most_visit_section_id' => null,
		'article_big_img' => null,
		'liveid' => (int) 24811,
		'created' => object(Cake\I18n\FrozenTime) {},
		'modified' => object(Cake\I18n\FrozenTime) {},
		'edate' => '',
		'tags' => [
			[maximum depth reached]
		],
		'category' => object(App\Model\Entity\Category) {},
		'[new]' => false,
		'[accessible]' => [
			[maximum depth reached]
		],
		'[dirty]' => [[maximum depth reached]],
		'[original]' => [[maximum depth reached]],
		'[virtual]' => [[maximum depth reached]],
		'[hasErrors]' => false,
		'[errors]' => [[maximum depth reached]],
		'[invalid]' => [[maximum depth reached]],
		'[repository]' => 'Articles'
	
	},
	'articleid' => (int) 24630,
	'metaTitle' => 'LATEST NEWS UPDATES | SC ruling on clinical trials',
	'metaKeywords' => 'medicines,Clinical Trials,drug trial,Health,Law and Justice',
	'metaDesc' => '
-The Telegraph


&nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...',
	'disp' => '<div style="text-align: justify">-The Telegraph</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.</p><p style="text-align: justify">A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.</p><p style="text-align: justify">The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.</p><p style="text-align: justify">The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.</p><p style="text-align: justify">The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.</p><p style="text-align: justify">The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.</p><p style="text-align: justify">Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.</p><p style="text-align: justify">The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.</p><p style="text-align: justify">The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.</p><p style="text-align: justify">&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.</p>',
	'lang' => 'English',
	'SITE_URL' => 'https://im4change.in/',
	'site_title' => 'im4change',
	'adminprix' => 'admin'
]
$article_current = object(App\Model\Entity\Article) {

	'id' => (int) 24630,
	'title' => 'SC ruling on clinical trials',
	'subheading' => '',
	'description' => '<div style="text-align: justify">
-The Telegraph
</div>
<p style="text-align: justify">
&nbsp;
</p>
<p style="text-align: justify">
<em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.
</p>
<p style="text-align: justify">
A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.
</p>
<p style="text-align: justify">
The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.
</p>
<p style="text-align: justify">
The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.
</p>
<p style="text-align: justify">
The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.
</p>
<p style="text-align: justify">
The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.
</p>
<p style="text-align: justify">
Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.
</p>
<p style="text-align: justify">
The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.
</p>
<p style="text-align: justify">
The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.
</p>
<p style="text-align: justify">
&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.
</p>',
	'credit_writer' => 'The Telegraph, 21 April, 2014, http://www.telegraphindia.com/1140422/jsp/nation/story_18265525.jsp#.U1XdEdxdHVI',
	'article_img' => '',
	'article_img_thumb' => '',
	'status' => (int) 1,
	'show_on_home' => (int) 1,
	'lang' => 'EN',
	'category_id' => (int) 16,
	'tag_keyword' => '',
	'seo_url' => 'sc-ruling-on-clinical-trials-24811',
	'meta_title' => null,
	'meta_keywords' => null,
	'meta_description' => null,
	'noindex' => (int) 0,
	'publish_date' => object(Cake\I18n\FrozenDate) {},
	'most_visit_section_id' => null,
	'article_big_img' => null,
	'liveid' => (int) 24811,
	'created' => object(Cake\I18n\FrozenTime) {},
	'modified' => object(Cake\I18n\FrozenTime) {},
	'edate' => '',
	'tags' => [
		(int) 0 => object(Cake\ORM\Entity) {},
		(int) 1 => object(Cake\ORM\Entity) {},
		(int) 2 => object(Cake\ORM\Entity) {},
		(int) 3 => object(Cake\ORM\Entity) {},
		(int) 4 => object(Cake\ORM\Entity) {}
	],
	'category' => object(App\Model\Entity\Category) {},
	'[new]' => false,
	'[accessible]' => [
		'*' => true,
		'id' => false
	],
	'[dirty]' => [],
	'[original]' => [],
	'[virtual]' => [],
	'[hasErrors]' => false,
	'[errors]' => [],
	'[invalid]' => [],
	'[repository]' => 'Articles'

}
$articleid = (int) 24630
$metaTitle = 'LATEST NEWS UPDATES | SC ruling on clinical trials'
$metaKeywords = 'medicines,Clinical Trials,drug trial,Health,Law and Justice'
$metaDesc = '
-The Telegraph


&nbsp;


New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.


A bench of...'
$disp = '<div style="text-align: justify">-The Telegraph</div><p style="text-align: justify">&nbsp;</p><p style="text-align: justify"><em>New Delhi: </em>The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India.</p><p style="text-align: justify">A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs.</p><p style="text-align: justify">The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials.</p><p style="text-align: justify">The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as &quot;guinea pigs&quot; for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India.</p><p style="text-align: justify">The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds.</p><p style="text-align: justify">The court also asked why the government does not set up a &quot;body or an office&quot; to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials.</p><p style="text-align: justify">Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. &quot;A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing,&quot; the bench said.</p><p style="text-align: justify">The Supreme Court had last month expressed shock at what it said was a &quot;disturbing&quot; figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012.</p><p style="text-align: justify">The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation.</p><p style="text-align: justify">&quot;We want the government to only allow clinical trials of drugs that will be made available to Indian population,&quot; said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.</p>'
$lang = 'English'
$SITE_URL = 'https://im4change.in/'
$site_title = 'im4change'
$adminprix = 'admin'

include - APP/Template/Layout/printlayout.ctp, line 8
Cake\View\View::_evaluate() - CORE/src/View/View.php, line 1413
Cake\View\View::_render() - CORE/src/View/View.php, line 1374
Cake\View\View::renderLayout() - CORE/src/View/View.php, line 927
Cake\View\View::render() - CORE/src/View/View.php, line 885
Cake\Controller\Controller::render() - CORE/src/Controller/Controller.php, line 791
Cake\Http\ActionDispatcher::_invoke() - CORE/src/Http/ActionDispatcher.php, line 126
Cake\Http\ActionDispatcher::dispatch() - CORE/src/Http/ActionDispatcher.php, line 94
Cake\Http\BaseApplication::__invoke() - CORE/src/Http/BaseApplication.php, line 235
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\RoutingMiddleware::__invoke() - CORE/src/Routing/Middleware/RoutingMiddleware.php, line 162
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Routing\Middleware\AssetMiddleware::__invoke() - CORE/src/Routing/Middleware/AssetMiddleware.php, line 88
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Error\Middleware\ErrorHandlerMiddleware::__invoke() - CORE/src/Error/Middleware/ErrorHandlerMiddleware.php, line 96
Cake\Http\Runner::__invoke() - CORE/src/Http/Runner.php, line 65
Cake\Http\Runner::run() - CORE/src/Http/Runner.php, line 51

SC ruling on clinical trials

-The Telegraph   New Delhi: The Supreme Court today asked the Centre to allow clinical trials on new pharmaceutical compounds only after ensuring to the extent possible that their potential benefits outweigh their risks and they are needed in India. A bench of Justices R.M. Lodha and Kurien Joseph, responding to a public interest petition by a non-government organisation called Swasthya Adhikar Manch, also told the Centre to ensure that the candidate compounds are innovations over existing drugs. The court, while issuing this directive, granted eight weeks time to the government to file an affidavit recording the steps it has taken to pay compensation for patients who had died or had suffered serious side effects linked to clinical trials. The NGO's petition has alleged that many patients in India have been used by pharmaceutical companies as "guinea pigs" for clinical trials of new pharmaceutical compounds with not enough emphasis on the safety of patients and whether the compounds being tested on volunteers are needed by India. The court told the additional solicitor general Siddhartha Luthra to ensure that the three parameters - related to safety, innovation and need for India - are followed by the government when it approves clinical trials of new pharmaceutical compounds. The court also asked why the government does not set up a "body or an office" to ensure that compensation is paid to patients who had faced serious side effects or to family members of patients who died through the clinical trials. Justice Lodha, heading the bench, said the body or the office thus appointed by the government could initially pay the compensation and thereafter recover the money from the pharmaceutical company concerned. "A person who is in need of relief must get compensation. You as a government must act as a facilitator. We don't know how much suffering a person must be undergoing," the bench said. The Supreme Court had last month expressed shock at what it said was a "disturbing" figure of 3,458 deaths and 14,320 serious side effects documented among volunteers of clinical trials that were conducted in India between 2005 and 2012. The government, through Luthra, had told the court that only 89 deaths and 506 serious adverse events were attributable to clinical trials - the other deaths among the participants were because of the natural progression of terminal illnesses. Luthra said about 85 victims have been paid compensation. "We want the government to only allow clinical trials of drugs that will be made available to Indian population," said Amulya Nidhi, a member of the Swasthya Adhikar Manch. Between January 2007 and June 2005, Nidhi said, the government had approved clinical trials involving more than 400 new pharmaceutical compounds, citing data submitted by the health ministry to the court. But only 17 of these drugs have been approved in India so far.